Halozyme Can't Block MSD From Selling Cancer Jab In Europe
A Dutch court refused to grant Halozyme an injunction against Merck Sharp & Dohme stopping it from marketing a cancer jab in a slew of European countries, ruling that the rival...To view the full article, register now.
Already a subscriber? Click here to view full article